Evidence map›Paper›PMID 29702628›Full record

ArticleMolecules (Basel, Switzerland)2018

Synthesis, Stability and Relaxivity of TEEPO-Met: An Organic Radical as a Potential Tumour Targeting Contrast Agent for Magnetic Resonance Imaging.

Maiju Soikkeli, Kaisa Horkka, Jani O Moilanen, Marjut Timonen, Jari Kavakka, Sami Heikkinen

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Contrast Agents Based on Human Serum Albumin and Nitroxides forInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maiju SoikkeliDepartment of Chemistry, University of Helsinki, P.O. Box 55, 00014 Helsinki, Finland. maiju-lotta.soikkeli@helsinki.fi.
Kaisa HorkkaDepartment of Chemistry, University of Helsinki, P.O. Box 55, 00014 Helsinki, Finland. kaisa.horkka@ki.se.
Jani O MoilanenDepartment of Chemistry, Nanoscience Centre, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland. jari.kavakka@storaenso.com.
Marjut TimonenHUS Helsinki Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, P.O. Box 340, 00029 HUS, Helsinki, Finland. jani.o.moilanen@jyu.fi.ORCID 0000-0002-2096-593X
Jari KavakkaDepartment of Chemistry, University of Helsinki, P.O. Box 55, 00014 Helsinki, Finland. marjut.timonen@hus.fi.
Sami HeikkinenDepartment of Chemistry, University of Helsinki, P.O. Box 55, 00014 Helsinki, Finland. sami.heikkinen@helsinki.fi.
University of Helsinki · FIUniversity of Jyväskylä · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a widespread and life-threatening disease and its early-stage diagnosis is vital. One of the most effective, non-invasive tools in medical diagnostics is magnetic resonance imaging (MRI) with the aid of contrast agents. Contrast agents that are currently in clinical use contain metals, causing some restrictions in their use. Also, these contrast agents are mainly non-specific without any tissue targeting capabilities. Subsequently, the interest has notably increased in the research of organic, metal-free contrast agents. This study presents a new, stable organic radical, TEEPO-Met, where a radical moiety 2,2,6,6-tetraethylpiperidinoxide (TEEPO) is attached to an amino acid, methionine (Met), as a potentially tumour-targeting moiety. We describe the synthesis, stability assessment with electron paramagnetic resonance (EPR) spectroscopy and relaxation enhancement abilities by an in vitro nuclear magnetic resonance (NMR) and phantom MRI studies of TEEPO-Met. The new compound proved to be stable notably longer than the average imaging time in conditions mimicking a biological matrix. Also, it significantly reduced the relaxation times of water, making it a promising candidate as a novel tumour targeting contrast agent for MRI.

Indexed as

AnimalsContrast MediaCyclic N-OxidesElectron Spin Resonance SpectroscopyHeterocyclic CompoundsHumansMagnetic Resonance ImagingMethionineMolecular StructureNeoplasmsPhantoms, ImagingPiperidines2,2,6,6-tetraethylpiperidine nitroxideContrast MediaCyclic N-OxidesHeterocyclic CompoundsMethioninePiperidinescontrast agentsEPRmethionineMRInitroxidesNMRradicals

Identifiers

PMID29702628
PMCPMC6102570
OpenAlexW2801866154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.